Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Depreciation & Amortization (CF) (2017 - 2025)

Inspire Medical Systems' Depreciation & Amortization (CF) history spans 9 years, with the latest figure at $3.8 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 54.24% year-over-year to $3.8 million; the TTM value through Dec 2025 reached $14.0 million, up 113.08%, while the annual FY2025 figure was $14.0 million, 113.08% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $3.8 million at Inspire Medical Systems, up from $3.7 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $3.8 million in Q4 2025 and bottomed at $234000.0 in Q1 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $718000.0 (2023), against an average of $1.3 million.
  • The largest annual shift saw Depreciation & Amortization (CF) grew 25.13% in 2021 before it surged 262.81% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $344000.0 in 2021, then surged by 65.41% to $569000.0 in 2022, then surged by 43.59% to $817000.0 in 2023, then skyrocketed by 203.3% to $2.5 million in 2024, then surged by 54.24% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Depreciation & Amortization (CF) are $3.8 million (Q4 2025), $3.7 million (Q3 2025), and $3.4 million (Q2 2025).